Position
SYNTAX RESEARCH, INC. in Pfizer Inc
Back to the book · All holders of PFE
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $2.77K$24.90 → $28.08
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 871 | $21.7K | — | — | — | 0.0% |
| Q1 2026 | 871 | $24.5K | $28.08 | $2.77K | −$0 | 0.0% |